Skip to main content

Breadcrumb

  1. Home

Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)

Lung-MAP S1400K: c-MET Positive

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Lung-MAP S1400K: c-MET Positive

A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors

The MOTION Study - Treatment of LSS With the MILD Procedure

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about The MOTION Study - Treatment of LSS With the MILD Procedure

Adapting Critical Time Intervention to Support Inpatient Medical Care Transition

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Adapting Critical Time Intervention to Support Inpatient Medical Care Transition

The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients

A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease

Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)

Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)

CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 235
  • Page 236
  • Page 237
  • Page 238
  • Page 239
  • Page 240
  • Page 241
  • Page 242
  • Page 243
  • …
  • Next page Next
  • Last page Last
Subscribe to